 "medicine, drug, antibiotic, doctor, pharmaceuticals")
Indian Patent Office has refused patent application of Japanese drug manufacturer Otsuka Pharmaceuticals for certain forms of its anti-psychotic drug aripiprazole, a medicine it sells under the brand Abilify.
Torrent has been at loggerheads with Otsuka over the patent of Abilify in other countries earlier.
The patent application for “Hydrate A of Aripiprazole and a process of preparation thereof”, was filed by Otsuka Pharma in December 2002. Torrent Pharma filed its pre-grant opposition alleging that the invention claimed are already published. It stressed on the clause in the Patents Act, which restricts incremental innovations from claiming for patents,
Torrent has been at loggerheads with Otsuka over the patent of Abilify in other countries earlier.
The patent application for “Hydrate A of Aripiprazole and a process of preparation thereof”, was filed by Otsuka Pharma in December 2002. Torrent Pharma filed its pre-grant opposition alleging that the invention claimed are already published. It stressed on the clause in the Patents Act, which restricts incremental innovations from claiming for patents,
